Evidence map›Paper›PMID 25266961›Full record

ArticleOsteoarthritis and cartilage2015

Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression.

P A Band, J Heeter, H-G Wisniewski, V Liublinska, C W Pattanayak, R J Karia, T Stabler, E A Balazs, V B Kraus

Open access · bronzeAbstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Management of osteoarthritis: From drug molecules to nano/micromedicines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  20. Methods for isolating and analyzing physiological hyaluronan: a review.American journal of physiology. Cell physiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

P A BandNYU School of Medicine, New York, NY, USA; NYU Hospital for Joint Diseases, New York, NY, USA. Electronic address: philip.band@nyumc.org.
J HeeterMatrix Biology Institute, Fort Lee, NJ, USA.
H-G WisniewskiNYU School of Medicine, New York, NY, USA. Electronic address: hans-georg.wisniewski@nyumc.org.
V LiublinskaHarvard University, Cambridge, MA, USA. Electronic address: vliublin@fas.harvard.edu.
C W PattanayakWellesley College, Wellesley, MA, USA.
R J KariaNYU Hospital for Joint Diseases, New York, NY, USA.
T StablerDuke University School of Medicine, Durham, NC, USA.
E A BalazsMatrix Biology Institute, Fort Lee, NJ, USA.
V B KrausDuke University School of Medicine, Durham, NC, USA. Electronic address: vbk@duke.edu.
Duke University · USMatrix Biology Institute · USNew York University Langone Orthopedic Hospital · USHarvard University Press · USNew York University · USWellesley College · US

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
Thermally-Triggered Intra-articular Drug Delivery for OAP01AR050245 · NIAMS · DUKE UNIVERSITY · PI GUILAK, FARSHID · 2003 to 2012
$11.5M
STRATEGIES TO PREDICT OSTEOARTHRITIS PROGRESSIONR01AR048769 · NIAMS · DUKE UNIVERSITY · PI KRAUS, VIRGINIA B. · 2002 to 2006
$1.7M
NIAMS NIH HHS P01 AR050245NIAMS NIH HHS R01 AR048769NIAMS NIH HHS R01AR48769NIA NIH HHS 5P30 AG028716NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

objectiveWe investigated the relationship between the molecular weight (MW) distribution of hyaluronan (HA) in synovial fluid (SF) and risk of knee osteoarthritis (OA) progression.

methodsHA MW was analyzed for 65 baseline knee SFs. At 3-year follow-up, knees were scored for change in joint space narrowing (JSN), osteophyte (OST) progression, or occurrence of total knee arthroplasty (TKA). HA MW distribution was analyzed using agarose gel electrophoresis (AGE), and its relationship to OA progression was evaluated using logistic regression. The association between HA MW and self-reported baseline knee pain was analyzed using Pearson's correlation coefficients.

resultsKnee OA was categorized as non-progressing (OST-/JSN-, 26 knees, 40%), or progressing based on OST (OST+/JSN-, 24 knees, 37%), OST and JSN (OST+/JSN+, 7 knees, 11%) or total knee arthroplasty (TKA, 8 knees, 12%). The MW distribution of HA in baseline SFs was significantly associated with the odds of OA progression, particularly for index knees. After adjusting for age, gender, BMI, baseline X-ray grade and pain, each increase of one percentage point in %HA below 1 million significantly increased the odds of JSN (odds ratios (OR) = 1.45, 95% CI 1.02-2.07), TKA or JSN (OR = 1.24, 95%CI 1.01-1.53) and the odds of any progression (OR = 1.16, 95% CI 1.01-1.32). HA MW distribution significantly correlated with pain.

conclusionThese data suggest that the odds of knee OA progression increases as HA MW distribution shifts lower and highlight the value of reporting MW distribution rather than just average MW values for HA.

Indexed as

AgedDisease ProgressionFemaleHumansHyaluronic AcidMaleMiddle AgedMolecular WeightOsteoarthritis, KneeRiskSynovial FluidHyaluronic AcidHyaluronanMolecular weightOsteoarthritis progressionSynovial fluid

Identifiers

PMID25266961
PMCPMC4375131
OpenAlexW2001137847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.